One strategy to limit the ability of cells to exclude Ara-C and its monophosphorylated form (Ara-CMP) is to inhibit the functioning of ABCC4, a transmembrane protein belonging to the ATP-binding cassette transporter superfamily (ABC) and highly expressed in AML [31,37,51,67,78]. Here, ABCC4 is linked to acute myeloid leukemia.